Inflammatory manifestations in chronic granulomatous disease (CGD).
about
NADPH oxidase-2 derived ROS dictates murine DC cytokine-mediated cell fate decisions during CD4 T helper-cell commitment.Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species.Gene therapy of chronic granulomatous disease: the engraftment dilemmaMitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)Role of p47phox in antigen-presenting cell-mediated regulation of humoral immunity in mice.Adaptive immune defects against glycoantigens in chronic granulomatous disease via dysregulated nitric oxide productionInflammation and repeated infections in CGD: two sides of a coin.Copper homeostasis at the host-pathogen interfacep47(phox) directs murine macrophage cell fate decisions.Maintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease.p47phox-deficient immune microenvironment signals dysregulate naive T-cell apoptosis.Recent insights into the pathobiology of innate immune deficienciesPP2A-dependent control of transcriptionally active FOXO3a in CD8(+) central memory lymphocyte survival requires p47(phox).Orthopaedic case of the month: Painless right knee mass in 32-year-old manResidual NADPH oxidase activity and isolated lung involvement in x-linked chronic granulomatous disease.Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.Decreased STAT5 phosphorylation and GATA-3 expression in NOX2-deficient T cells: role in T helper developmentNADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells.p47phox deficiency induces macrophage dysfunction resulting in progressive crystalline macrophage pneumoniaSalmonella enterica serovar Typhimurium mutants completely lacking the F(0)F(1) ATPase are novel live attenuated vaccine strains.Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression.Lipid peroxidation causes endosomal antigen release for cross-presentation.Hyper-responsive Toll-like receptor 7 and 9 activation in NADPH oxidase-deficient B lymphoblasts.Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.T cells and autoimmune kidney disease.The role of monogenic disease in children with very early onset inflammatory bowel disease.Newcomers in paediatric GI pathology: childhood enteropathies including very early onset monogenic IBD.Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease.Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: implications for chronic granulomatous disease.Neutrophils confer T cell resistance to myeloid-derived suppressor cell-mediated suppression to promote chronic inflammation.Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosisInflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous diseaseRapid detection of intracellular p47phox and p67phox by flow cytometry; useful screening tests for chronic granulomatous disease.Cell-specific Activation of the Nrf2 Antioxidant Pathway Increases Mucosal Inflammation in Acute but Not in Chronic Colitis.Noninfectious Manifestations and Complications of Chronic Granulomatous Disease.New onset colitis in an adult patient with chronic granulomatous disease treated with hematopoietic stem cell transplantation: a diagnostic dilemma.Reactive Oxygen Species Deficiency Due to Ncf1-Mutation Leads to Development of Adenocarcinoma and Metabolomic and Lipidomic Remodeling in a New Mouse Model of Dextran Sulfate Sodium-Induced Colitis
P2860
Q34092437-FF20EACD-B667-4FCF-A5F5-0BBFA94F3042Q34200205-831970E7-F204-4F58-81BC-614D14C6A7BDQ34473374-3A338DA9-F094-4FD7-B8B0-05B8EBC55BD4Q34681297-8ACD201C-E7FB-4F30-9F41-265C5A304B78Q35072741-EB4FA86A-0E3B-4502-90D7-24FE5EF874A6Q35547544-CA0A8080-789C-4AC4-8621-D792AE3D907DQ35644145-43F1F2ED-0766-4785-B8CB-78BD7E552C29Q35922366-4EE8BB48-7A4B-4191-860F-E18A711D3F55Q35952015-904D3505-D56C-407E-B892-0832EF6E97F6Q36071413-666C4466-0426-4BDE-8A92-1B8A7D76153BQ36104296-D0F43AAE-B18E-43F3-B95E-4824716D04B1Q36125707-7176CCC2-03A3-423F-8E32-5DDCB5774F20Q36211448-F06BD4AB-C01B-425A-8EEE-86EE90E9BBEDQ36381638-2ED7C87A-E919-46AC-A8AE-3CE3BB85E3AAQ36410497-E2894A0C-4F1F-462B-8022-3951D0A609C9Q36517880-9C54451E-3F49-46A2-90FA-474B003256E2Q36953180-FA4EA618-1008-46EA-A678-8085DCCA28A7Q37002001-0F621C2C-7A4D-4A7E-A8E4-659505D7337FQ37073789-13398C4B-F575-4B36-95C4-2D142FAD6423Q37504399-19CA795E-347C-4222-80DE-D7CC4937BD3AQ38048847-ABA5FBAE-31AA-4CE0-A8B8-83C39A71D247Q38608424-674ADB63-789E-43EE-BD9B-5F4EB6969C76Q38837849-4FA6C744-E760-4754-B932-EE1407F5F31FQ38911356-FFBD6D97-A0CE-46DD-A88A-FB105DEF54CEQ39175811-A104B078-53E1-4997-BE01-D4F08914D19CQ39430706-F9AD5BDD-FC64-4ED6-9D56-9002495F2B4DQ39440937-30EEE19C-EA10-483D-8DAF-5E947337A53EQ39684886-E46589A9-36B7-4735-99EF-061F4E0F8C49Q39830520-C0F7BDB4-9C42-4626-9685-87730A342D8EQ40488825-7331CAC3-23B8-477C-9146-35AF2CE3F646Q40941456-4402C948-F93E-4BF7-AF40-003B75AC79FFQ42083816-2778C6C4-8CE2-4459-9EF6-0AC6F2477156Q45353388-6D0CDF32-6090-4B59-A451-919256E1CA1CQ46467931-90819CD5-1DE8-43C1-8317-90A7DE85D207Q55021826-6DCE2204-7623-4F3B-9BC4-A56466C75973Q55282167-4506382F-4295-4D92-B5A5-0EC31128B369Q55285116-D3FCF50F-741C-4F91-B386-DC78DE00FDAA
P2860
Inflammatory manifestations in chronic granulomatous disease (CGD).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammatory manifestations in chronic granulomatous disease (CGD).
@en
Inflammatory manifestations in chronic granulomatous disease
@nl
type
label
Inflammatory manifestations in chronic granulomatous disease (CGD).
@en
Inflammatory manifestations in chronic granulomatous disease
@nl
prefLabel
Inflammatory manifestations in chronic granulomatous disease (CGD).
@en
Inflammatory manifestations in chronic granulomatous disease
@nl
P2860
P1476
Inflammatory manifestations in chronic granulomatous disease (CGD).
@en
P2093
S D Rosenzweig
P2860
P2888
P304
P356
10.1007/S10875-007-9160-5
P478
28 Suppl 1
P577
2008-01-12T00:00:00Z